C07D 507/00
Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by
Official title: Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D505/00; Such ring systems being further condensed
C07D507/00 (Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C07D- Granted patents
- 4
- Published applications
- 8
- Assignees
- 3
- Inventors
- 15
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 0 |
| 2022 | 2 | 3 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Biologically active molecules, conjugates thereof, and therapeutic uses5 Aug 2025US 12,378,258 B2Regeneron Pharmaceuticals, Inc.
- Biologically active molecules, conjugates thereof, and therapeutic uses31 May 2022US 11,345,715 B2Regeneron Pharmaceuticals, Inc.
- Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same4 Jan 2022US 11,214,568 B2California Institute of Technology
- Biologically active molecules, conjugates thereof, and therapeutic uses25 Feb 2020US 10,570,151 B2Regeneron Pharmaceuticals, Inc.
- Biologically active molecules, conjugates thereof, and therapeutic uses5 Mar 2026US 2026/0062423 A1Regeneron Pharmaceuticals, Inc.
- Biologically active molecules, conjugates thereof, and therapeutic uses20 Oct 2022US 2022/0332729 A1Regeneron Pharmaceuticals, Inc.
- Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same7 Jul 2022US 2022/0213081 A1California Institute of Technology
- Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same21 Apr 2022US 2022/0119377 A1California Institute of Technology
- Biologically active molecules, conjugates thereof, and therapeutic uses3 Sep 2020US 2020/0277306 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents